{"id":"W4410349213","doi":"10.1016/j.lungcan.2025.108583","title":"Real-world survival outcomes, treatment patterns, and impact of PD-L1 expression among patients with unresectable, stage III NSCLC treated with CRT → durvalumab in Canada: The RELEVANCE study","year":2025,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"Public Health Ontario; AstraZeneca (Canada); Institut universitaire de cardiologie et de pneumologie de Québec; Dalhousie University; Université Laval; Queen Elizabeth II Health Sciences Centre; Université de Montréal; University of Calgary; Centre Hospitalier de l’Université de Montréal; BC Cancer Agency; Ottawa Hospital","funders":"AstraZeneca","keywords":"Durvalumab; Medicine; Stage (stratigraphy); Oncology; Internal medicine; Overall survival; Relevance (law); Cancer; Immunotherapy; Nivolumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003939524,0.0003867851,0.0004135258,0.0005959197,0.001217207,0.001170949,0.0009889446,0.0005917001,0.001484065],"category_scores_gemma":[0.001792321,0.000276386,0.0007608098,0.002318432,0.0007288394,0.0004896065,0.0007184723,0.0009096998,0.0002080574],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02483176,"about_ca_system_score_gemma":0.02085469,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9654168,"about_ca_topic_score_gemma":0.9774348,"domain_scores_codex":[0.9993,0.00006102861,0.00004010458,0.0001482081,0.0001530909,0.0002974861],"domain_scores_gemma":[0.9986295,0.00009395633,0.0003683714,0.00006603054,0.0003999137,0.0004424387],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004483656,0.00004312751,0.9959269,0.00002437981,0.0001109767,0.00006041995,0.0001584018,0.0001589477,0.0001327089,0.00005789787,0.0007372969,0.002140597],"study_design_scores_gemma":[0.00004978363,0.0000659726,0.9978843,0.0000158066,0.0001009038,0.00007870288,0.00061196,0.0003253708,0.00005269524,0.00003158892,0.0007689846,0.00001390794],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933788,0.0004032233,0.00004268448,0.0003316334,0.000009372593,0.00002396347,0.004868071,0.000006342709,0.0009360482],"genre_scores_gemma":[0.9972233,0.0001963906,0.00006027285,0.0001018126,0.000008746157,0.00001040988,0.00207411,0.00000310868,0.0003219017],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03458321,"threshold_uncertainty_score":0.1801679,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008585620769715262,"score_gpt":0.2952468966671313,"score_spread":0.286661275897416,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}